EN 
FR 
Specialty Areas
We specialize in supporting your challenging projects where sample sizes are intricate or trials exhibit heightened complexity. Discover our tailored solutions and expertise across diverse areas.
Strategic Analytical Methods for Unique Challenges
Experience the transformative potential of integrated solutions with Cytel’s strategic analytics. By intelligently connecting data, technology, and analytics, we streamline clinical development, driving innovation while reducing risk. Our comprehensive approach enables you to navigate complexity, make informed decisions, and deliver life-changing treatments faster, all while prioritizing patient outcomes and leading the industry toward a future where data guides every decision.
Our Expertise
Rare Disease Studies
Pave the way for breakthroughs with our rare disease expertise, delivering tailored solutions to navigate the complexities of rare disease studies.
Oncology Studies
Propel oncology research forward with our specialized solutions, optimizing trial design and leveraging real-world evidence to accelerate innovation.
Pediatric Studies
Accelerate pediatric medicine breakthroughs with our tailored studies, addressing unique challenges and minimizing sample size complexities for efficient, impactful research.
Post-Authorization Safety Studies
Safeguard patient health with our Post-Authorization Safety Studies (PASS), providing rigorous post-authorization safety assessments to ensure treatment safety and efficacy.
Decentralized Trials
Embrace the future of clinical research with decentralized trials, leveraging innovative approaches to enhance patient engagement and trial efficiency.
External Controls
Expand your trial capabilities with external control arms, harnessing real-world data to enhance study design and generate robust evidence.
Synthetic Controls
Harness the power of synthetic control arms to optimize trial efficiency and generate reliable comparative data, driving innovation in clinical research.
>200
Team of RWE, HEOR and regulatory specialists
>7,000
Strong network of physicians and oncology experts in the US
30%
Increase in complexity of clinical trials
>50%
New trials starts in Oncology and Rare Diseases
Claim your free 30-minute strategy session
Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug's probability of success and plot a clearer route to market.
